Brisbane Clinical Trials
The Antibody Study
The study drug is a potential new treatment for autoimmune diseases.
3 screening visits + 4 nights
9 visits
This treatment is based on an antibody which stops the development of autoimmune diseases.
Autoimmune diseases occur when the immune system mistakenly attacks the body, leading to inflammation and tissue damage in organs. Immune diseases are among the fastest growing chronic conditions in Australia, currently affecting almost 5% of Australians. Immune diseases have a significant cost to the individual and the community, so there is a high demand for new treatments.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Eligibility
Biological Sex Healthy males and females not working in an occupation that requires Hepatitis B vaccination
Age 18 – 55 years old, inclusive
BMI 18 - 32 kg/m²
Body Weight 50-100kg
Medical History No significant medical history
Medications Not taking any medication
Smoking History Non-smokers and casual smokers only (no more than 5 cigarettes per week)